Delivery Order SPE2DB22D3011-SPE2DB24FQ1DE
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $25,778 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,564,306 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,288.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564288248 Boostrix TDAP vaccine syringes. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC enables the DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,583.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,176,760 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml) at a ceiling value of $4,228.80. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,530.80 firm fixed price delivery order contract to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award is part of a larger $999,999,999.00 indefinite delivery contract between DLA and Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,564,353 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a ceiling value of $36,781.92 and an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $53,889.29 contract has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA that serves as the primary vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract, valued at $1,603.98, has a completion date of February 2, 2024 and was awarded on February 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,791.27 firm-fixed price contract has an ultimate completion date of August 19, 2024. Amerisourcebergen, the prime contractor, is not operating under a set-aside designation for this award. As a key supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a $1,274.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...